PubMed Central, Li, De-Pei, et al
PubMed laboratory research record [PMID: 22709675] PubMed record related to this compound for laboratory literature review
This emerging mechanism substantially expands our understanding of SFNs anticancer portfolio, particularly against therapy-resistant malignancies
Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth
Carnitine supplements are used to enhance physical performance and to treat fatigue, cardiovascular disease, diabetes, obesity, chronic fatigue syndrome, liver disorders, and cancer
Moreover, carnitine may have synergistic effects when combined with other supplements, such as creatine and glutamine, which can enhance athletic performance and muscle growth